Literature DB >> 18413405

Hydroxychloroquine: the cornerstone of lupus therapy.

G Ruiz-Irastorza, M A Khamashta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18413405     DOI： 10.1177/0961203307086643

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  21 in total

Review 1.  The Diagnosis and Treatment of Systemic Lupus Erythematosus.

Authors:  Annegret Kuhn; Gisela Bonsmann; Hans-Joachim Anders; Peter Herzer; Klaus Tenbrock; Matthias Schneider
Journal:  Dtsch Arztebl Int       Date:  2015-06-19       Impact factor: 5.594

Review 2.  [Tapering and termination of immunosuppressive therapy : Systemic lupus erythematosus].

Authors:  M Aringer; N Leuchten; R Fischer-Betz
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

3.  Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.

Authors:  L B Lewandowski; L E Schanberg; N Thielman; A Phuti; A A Kalla; I Okpechi; P Nourse; P Gajjar; G Faller; P Ambaram; H Reuter; G Spittal; C Scott
Journal:  Lupus       Date:  2016-08-19       Impact factor: 2.911

4.  Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).

Authors:  April M Jorge; Na Lu; Yuqing Zhang; Sharan K Rai; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

5.  Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.

Authors:  Gabriela Schmajuk; Jinoos Yazdany; Laura Trupin; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

6.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Authors:  R R Winkelmann; Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-01

Review 7.  Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.

Authors:  Yusuf Cem Kaplan; Jak Ozsarfati; Cheri Nickel; Gideon Koren
Journal:  Br J Clin Pharmacol       Date:  2016-02-16       Impact factor: 4.335

8.  Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.

Authors:  Elisheva Pokroy-Shapira; Ilana Gelernter; Yair Molad
Journal:  Clin Rheumatol       Date:  2014-02-19       Impact factor: 2.980

9.  Sharp decline in hydroxychloroquine dosing-analysis of 17,797 initiators from 2007 to 2016.

Authors:  Ronald B Melles; April M Jorge; Michael F Marmor; Yuqing Zhang; Hyon K Choi
Journal:  Clin Rheumatol       Date:  2018-04-26       Impact factor: 2.980

10.  Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?

Authors:  Cátia Cunha; Suceena Alexander; Damien Ashby; Janet Lee; Gary Chusney; Tom D Cairns; Liz Lightstone
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.